[FDMT] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
25-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -6.80%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 20,723 3,129 18,038 13,612 6,986 14,130 5,790 23.66%
PBT -100,837 -107,494 -71,317 -56,693 -49,306 -9,551 -11,223 44.16%
Tax 0 -6,418 -3,020 -152 3,633 848 -89 -
NP -100,837 -101,076 -68,297 -56,541 -52,939 -9,551 -11,223 44.16%
Tax Rate - - - - - - - -
Total Cost 121,560 104,205 86,335 70,153 59,925 23,681 17,013 38.76%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -486.59 -3,230.30 -378.63 -415.38 -757.79 -67.59 -193.83 16.57%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -2.58 -3.12 -2.46 -2.12 -2.00 -0.76 -0.76 22.58%
EPS Diluted -2.58 -3.12 -2.46 -2.12 -2.00 -0.76 -0.76 22.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.